841 related articles for article (PubMed ID: 8723352)
1. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
2. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Lukas J; Petersen BO; Holm K; Bartek J; Helin K
Mol Cell Biol; 1996 Mar; 16(3):1047-57. PubMed ID: 8622649
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
5. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
[TBL] [Abstract][Full Text] [Related]
6. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.
Buchmann AM; Swaminathan S; Thimmapaya B
Mol Cell Biol; 1998 Aug; 18(8):4565-76. PubMed ID: 9671466
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
10. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
12. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
15. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
16. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.
Müller H; Moroni MC; Vigo E; Petersen BO; Bartek J; Helin K
Mol Cell Biol; 1997 Sep; 17(9):5508-20. PubMed ID: 9271426
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
20. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]